Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

Circulation

Volumn 94, Issue 7, 1996, Pages 1690-1697

  Van der Giessen, Willem J ^a,d   Lincoff, A Michael ^b   Schwartz, Robert S ^c   Van Beusekom, Heleen M M ^a   Serruys, Patrick W ^a   Holmes Jr , David R ^c   Ellis, Stephen G ^b   Topol, Eric J ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

angioplasty; arteries; coronary disease; stents

Indexed keywords

MACROGOL; POLY(ORTHO ESTER); POLYBUTYLENE TEREPHTHALATE; POLYCAPROLACTONE; POLYETHYLENE TEREPHTHALATE; POLYGLYCOLIC ACID; POLYHYDROXYBUTYRATE VALERATE; POLYLACTIC ACID; POLYMER; POLYURETHAN; SILICON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY THROMBOSIS; NONHUMAN; PRIORITY JOURNAL; STENT; THROMBOGENESIS; TISSUE REACTION;

EID: 0029761378     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1690     Document Type: Article

References (45)

1. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
2. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson JT, on behalf of the EPIC Investigators. Randomised trial of coronary intervention with antibody against IIb/ IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 1994;343:881-886.
3. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morèl M, for the Benestent Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
4. Fishman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Snaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
5. Topol EJ. Caveats about elective coronary stenting. N Engl J Med. 1994;331:539-541.
6. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
7. Morice MC, Breton C, Bunouf P, Cattan S, Eltchaninoff H, Henry M, Joly P, Livarek B, Pilliere R, Rioux P, Spaulding C, Zemour G. Coronary stenting without anticoagulant, without intravascular ultrasound; results of the French registry. Circulation. 1995;92(suppl I):I-796. Abstract.
8. King SB III. Vascular stents and atherosclerosis. Circulation. 1989; 79:460-462.
9. Serruys PW, Beatt KJ, van der Giessen WJ. Stenting of coronary arteries: are we the sorcerer's apprentice? Eur Heart J. 1989;10: 774-782.
10. Muller DWM, Topol EJ. Implantable devices in the coronary artery: from metal to genes. Trends Cardiovasc Med. 1991;1:225-232.
11. Wilensky RL, March KL, Gradus-Pizlo I, Speady AJ, Hathaway DR. Methods and devices for local drug delivery in coronary and peripheral arteries. Trends Cardiovasc Med. 1993;3:163-170.
12. Chapman GD, Gammon RS, Bauman RP, Howell S, Clark H, Mikat EM, Palmos L, Buller CE, Stack RS. A bioabsorbable stent: initial experimental results. Circulation. 1990;82(suppl III):III-72. Abstract.
13. Wilensky RL, March KL, Hathaway DR. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am Heart J. 1991;122:1136-1140.
14. Cox DA, Anderson PG, Roubin GS, Chou C, Agrawal SK, Cavender JB. Effect of local delivery of heparin and methotrexate on neointimal proliferation in stented porcine coronary arteries. Coron Artery Dis. 1992;3:237-248.
15. Murphy JG, Schwartz RS, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR Jr. Percutaneous polyester stents in porcine coronary arteries: initial experience with polyethylene terephthalate stents. Circulation. 1992;86:1596-1604.
16. van der Giessen WJ, Slager CJ, van Beusekom HMM, van Ingen Schenau DS, Huijts RA, Schuurbiers JC, de Klein WJ, Serruys PW, Verdouw PD. Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J Intervent Cardiol. 1992; 5:175-185.
17. van der Giessen WJ, van Beusekom HMM, van Houten CD, van Woerkens LJ, Verdouw PD, Serruys PW. Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Coron Artery Dis. 1992;3:631-640.
18. Homsy CA. Biocompatibility in selection of materials for implantation. J Biomed Mater Res. 1970;4:341-356.
19. Bakker D, van Blitterswijk CA, Hesseling SC, Grote JJ, Daems WT. The effect of implantation site on phagocyte/polymer interaction and fibrous capsule formation. Biomaterials. 1988;9:14-23.
20. Böstman OM. Absorbable implants for the fixation of fractures. J Bone Joint Surg Am. 1991;73-A:148-153.
21. Chegini N, Hay DL, von Fraunhofer JA, Masterson BJ. A comparative scanning electron microscopic study on degradation of absorb-able ligating clips in vivo and in vitro. J Biomed Mater Res. 1988; 22:71-79.
22. Rosilio V, Benoit JP, Deyme M, Thies C, Madelmont G. A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(d,1-lactide-co-glycolide). J Biomed Mater Res. 1991;25:667-682.
23. Frazza EJ, Schmitt EE. A new absorbable suture. J Biomed Mater Res. 1971;4:43-58.
24. Miller RA, Brady JM, Cutright DE. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J Biomed Mater Res. 1977;11:711-719.
25. Pitt CG. Poly-ε-caprolactone and its copolymers. In: Chasin Mi Langer R, eds. Biodegradable Polymers as Drug Delivery Systems. New York, NY: Marcel Dekker Inc; 1990.
26. Woodward SC, Brewer PS, Moatamed F, Schindler A, Pitt CG. The intracellular degradation of poly (ε-caprolacton). J Biomed Mater Res. 1985;19:437-444.
27. Miller ND, Williams DF. On the biodegradation of poly-β-hydroxybutyrate (PHB) homopolymer and poly-β-hydroxybutyrate-hydroxy-valerate copolymers. Biomaterials. 1987;8:129-137.
28. Koosha F, Muller RH, Davis SS. Polyhydroxybutyrate as a drug carrier. Crit Rev Ther Drug Carrier Syst. 1989;6:117-130.
29. Bora FW, Bednar JM, Osterman AL, Brown MJ, Sumner AJ. Prosthetic nerve grafts: a resorbable tube as an alternative to autogenous nerve grafting. J Hand Surg (Am). 1987;12A(pt I):685-692.
30. Heller J, Fritzinger BK, Ng SY, Penhale DWH. In vitro and in vivo release of levonorgestrel from poly(orthoesters). J Controlled Release. 1985;1:225-232.
31. Bakker D, van Blitterswijk CA, Daems WT, Grote JJ. Biocompatibility of six elastomers in vitro. J Biomed Mater Res. 1988;22: 423-439.
32. Bakker D, van Blitterswijk CA, Hesseling SC, Koerten HK, Kuijpers W, Grote JJ. Biocompatibility of a polyether urethane, polypropylene oxide, and a polyether polyester copolymer: a qualitative and quantitative study of three alloplastic tympanic membrane materials in the rat middle ear. J Biomed Mater Res. 1990;24:489-515.
33. Coury AJ, Slaikeu PC, Cahalan FT, Stokes KB. Medical applications of implantable polyurethanes; current issues. Prog Rubber Plastics Technology. 1987;3:24-37.
34. Frisch EE. Silicones in artificial organs. In: Gebelein CG, ed. Polymeric Materials and Artificial Organs. Washington, DC: American Chemical Society; 1984:63-97.
35. Goidoin R, Couture J. Polyester prostheses: the outlook for the future. In: Sharma CP, Szycher M, eds. Blood Compatible Materials and Devices. Lancaster, Pa: Technomic Publishing Co Inc; 1991:221-237.
36. van der Giessen WJ, Serruys PW, van Beusekom HMM, van Woerkens LJ, van Loon H, Soei LK, Strauss BH, Beatt KJ, Verdouw PD. Coronary stenting with a new, radiopaque, balloon-expandable endoprosthesis in pigs. Circulation. 1991;83:1788-1798.
37. Hench LL, Ethridge EC. Biomaterials: the interfacial problem. Adv Biomed Eng. 1975;5:35-150.
38. Hårdhammer PA, van Beusekom HMM, Emanuelsson HU, Hofma SH, Albertsson PA, Verdouw PD, Serruys PW, van der Giessen WJ. Reduction of thrombotic events using heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation. 1996;93:423-430.
39. How TV. Mechanical properties of arteries and arterial grafts. In: Hastings GW, ed. Cardiovascular Biomaterials. London, England: Springer-Verlag Ltd; 1992:1-36.
40. Schatz R, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, Cleman MW, Cabin HS, Walker C, Stagg J, Buchbinder M, Teirstein PS, Topol EJ, Savage M, Perez JA, Curry RC, Whitworth H, Sousa E, Tio F, Almagor Y, Ponder R, Penn IM, Leonard B, Levine SL, Fish RD, Palmaz JC. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation. 1991;83:148-161.
41. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation. 1995;91:2995-3001.
42. Siefert KB, Albo D, Knowlton H, Lyman DJ. Effect of elasticity of prosthetic wall on patency of small diameter arterial prostheses. Surg Forum. 1979;30:206-208.
43. Lyman DJ, Fazzio J, Voorhees H, Robinson G, Albo D Jr. Compliance as a factor affecting the patency of a copolyurethane vascular graft. J Biomed Mater Res. 1978;12:337-345.
44. March KL, Mohanraj S, Ho PPK, Wilensky RL, Hathaway DR. Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. Circulation. 1994; 89:1929-1933.
45. Lincoff AM, Furst JG, Ellis SG, Topol EJ. Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery. J Am Coll Cardiol. 1994;23(suppl A): 18A. Abstract.